Overexpressed ARNTL2 correlated with advanced clinical tumor stages and grades, we also found that upregulation of ARNTL2 predicted poor overall survival and can serve as an independent prognostic variable in ccRCC. This evidence concerns the gene BMAL2 and nonpapillary renal cell carcinoma.